What is Evista?
Evista is a brand name for the drug Raloxifene, an oral selective estrogen receptor modulator which is used in the prevention of osteoporosis in postmenopausal women. Evista is a brand name owned by Eli Lilly.
Read more...
Reasons taken & Efficacy
| Reasons taken | # of patients | Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| Other | 8 | 0 | |||||
| Osteoporosis | 7 |
|
1 | ||||
| General health | 1 | 0 | |||||
| Bone Health | 1 | 0 | |||||
| Itching (pruritus) | 1 | 0 | |||||
| Balance hormones because of the Depro-Provera | 1 | 0 |
Mouse over the table for more information
Side Effects
Dosages
| 60 mg daily | ||
|---|---|---|
16
|
||
Stop Reasons
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
|
Doctor's advice
|
3 | 75% |
|
|
Expense
|
1 | 25% |
|
|
Personal research
|
1 | 25% |
|
|
Side effects too severe
|
1 | 25% |
|
|
Course of treatment ended
|
1 | 25% |
|
Adherence, Burden & Cost See details from patient evaluations ▼
See more information, including instructions, precautions, side effects, and interactions.
Report created on November 22, 2009.